Objective: To evaluate the clinical characteristics, diagnosis and treatment of primary tracheal adenoid cystic carcinoma.
Methods: The data of 11 patients with primary tracheal adenoid cystic carcinoma were reviewed. The age of the patients ranged from 30 to 49 years. The tumor situated at the upper trachea in 7 patients, including 2 invading the larynx and 1 invading the cricoid cartilage; at the middle trachea in 2, and at the lower trachea in 2. The surgical procedures included tracheal sleeve resection in 5 patients, with cricoid partial resection in 1; tracheal tumor curettement in 4; cervical trachea and larynx resection and tracheostomy in 2.
Results: All patients had an uneventful recovery. Stoma constriction occurred in 1 patients, and relapse in 1. There was no perioperative death.
Conclusion: For patients with primary tracheal adenoid cystic carcinoma, early diagnosis and surgical treatment are recommended.
Download full-text PDF |
Source |
---|
J Cardiothorac Surg
January 2025
Department of Cardiothoracic Surgery, The First People's Hospital of Neijiang, No. 1866, West Section of Hanan Avenue, Shizhong District, Neijiang, Sichuan, 641000, P.R. China.
Background: Primary mediastinal liposarcomas (PLMs) are extremely rare. Patients typically present with symptoms caused by tumor size, as the mass can compress surrounding tissues and organs. Here, we report a case of a large primary mediastinal liposarcoma that was successfully resected thoracoscopically.
View Article and Find Full Text PDFBMC Anesthesiol
January 2025
Department of Anesthesiology, Perioperative Medicine and Pain Management, 1611 NW 12, University of Miami, Miami, FL, 33136, USA.
Background: Prolonged tracheal extubation time is defined as an interval ≥ 15 min from the end of surgery to extubation. An earlier study showed that prolonged extubations had a mean 12.4 min longer time from the end of surgery to operating room (OR) exit.
View Article and Find Full Text PDFBMJ Open
January 2025
Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China
Introduction: Preclinical studies have shown that oxygen therapy can improve ischaemic brain tissue oxygen tension, reduce reperfusion injury after revascularisation, promote neuroregeneration and inhibit inflammatory responses potentially exerting a beneficial effect after endovascular treatment (EVT) in patients with acute ischaemic stroke (AIS). However, the optimal fraction of inspired oxygen (FiO) during EVT under general anaesthesia is currently unknown. Therefore, we are conducting a randomised controlled trial (RCT) to evaluate the impact of high-concentration oxygen vs low-concentration normobaric oxygen on early neurological function after EVT.
View Article and Find Full Text PDFBackground: Previously, a depth of anesthesia bispectral index (BIS™) <45 was considered lowand found to have no clinical benefit. A BIS <35 was considered very low and was not only without evident clinical benefit but also associated with a greater risk of postoperative delirium. We considered the association between BIS and the anesthetic dose of inhalational agents, quantified using the minimum alveolar concentration (MAC) fraction, which was the patient's end-tidal inhalational agent concentration divided by the agent's altitude- and age-adjusted minimum alveolar percentage concentration.
View Article and Find Full Text PDFTuberk Toraks
December 2024
Clinic of Pulmonary Medicine, Liv Vadi İstanbul Hospital, İstanbul, Türkiye.
Tracheal schwannomas are exceedingly rare, accounting for a minute fraction of primary tracheal tumors. They are classified into intraluminal and mixed types, with treatment strategies varying significantly between these subtypes. While thorax tomography is usually sufficient to distinguish intraluminal and mixed type, endobronchial ultrasonography (EBUS) can also be used in cases where the distinction cannot be made clearly with tomography.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!